Centrexion Therapeutics

Boston, United States · Founded 2013 · $192.4M raised

Employees
11–50
Founded
2013
Business Model
B2B
Total Funding
$192.4M
Last Round
$10.3M Venture RoundJun 2023
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Centrexion Therapeutics is a clinical-stage biopharmaceutical company developing a broad pipeline of novel, non-opioid, non-addictive therapies for chronic pain and immunology. Its mechanism-driven approach spans topical, injectable, and oral modalities, with partnerships with Lilly, Boehringer Ingelheim, Sanofi, and NIH validating its scientific platform. The company aims to be the premier pain therapeutics powerhouse by addressing safety and efficacy gaps in current treatments.

Summary

Centrexion Therapeutics is a Biotech company based in Boston, United States, founded in 2013. It has raised $192.4M in total across 6 rounds, most recently a $10.3M Venture Round in Jun 2023. Investors include New Enterprise Associates, Fidelity Management and Eli Lilly.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Debt FinancingDebt RoundJan 2024
$3.3M

Sign up to see all 7 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Centrexion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/centrexion-therapeutics"><img src="https://indexed.vc/api/badge/company/centrexion-therapeutics" alt="Centrexion Therapeutics on Indexed.vc" width="260" height="76" /></a>